TNF and Cowden disease: However, the advent of anti-tumor necrosis factor (anti-TNF) agents, including infliximab (IFX) and adalimumab, as treatments of CD has allowed the rapid achievement and maintenance of remission in patients of all ages, including pediatric patients (3–6).